University of Cambridge > Talks.cam > Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine > The AKT inhibitor capivasertib (AZD5363): from discovery to clinical proof concept

  Browse A-Z

Log in

Googledetails Microsoftdetails

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

The AKT inhibitor capivasertib (AZD5363): from discovery to clinical proof concept

Download to your calendar using vCal

  • UserDr Barry Davies, Director, Clinical Translation Scientific Alliances, AstraZeneca
  • ClockThursday 11 February 2021, 09:30-10:30
  • HouseOnline - Google Meet as below.

If you have a question about this talk, please contact Justin Holt .

Link to live lecture: https://meet.google.com/dji-ktvq-ezz

This talk is part of the Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

in person at LMB and Online IRC in Superconductivity Seminar Room, Cavendish Laboratory CUBASS

Other talks

Haematology and Palliative Care Overview of treatment for non-small cell lung cancer Teams Announced Morning Tea and Coffee Tea and Coffee Break Market Failure, Organ Shortage, Pandemic and Climate Change: The Architecture of Cooperation
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity